Self-reported alcohol abuse in HIV-HCV co-infected patients: A better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort)

Addiction

Volumn 108, Issue 7, 2013, Pages 1250-1258

  Marcellin, Fabienne ^a,b,c   Lions, Caroline ^a,b,c   Winnock, Maria ^d   Salmon, Dominique ^e,f   Durant, Jacques ^g   Spire, Bruno ^a,b,c   Mora, Marion ^a,b,c   Loko, Marc Arthur ^d   Dabis, François ^d   Dominguez, Stéphanie ^h   Roux, Perrine ^a,b,c   Carrieri, Maria Patrizia ^a,b,c  

^a AIX MARSEILLE UNIV   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d INSERM   (France)

^e AP HP ^*  (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^h HENRI MONDOR HOSPITAL   (France)

Author keywords

Alcohol abuse; HIV HCV co infection; Physicians' perceptions; Self reports; Virological rebound

Indexed keywords

ADULT; ALCOHOLISM; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEPACIVIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MIXED INFECTION; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK FACTOR; SELF REPORT; VIROLOGY; VIRUS LOAD; ARTICLE; HEPATITIS C VIRUS;

ADULT; ALCOHOLISM; COINFECTION; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SELF REPORT; VIRAL LOAD;

EID: 84878923719     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12149     Document Type: Article

References (38)

1. Hasse B., Ledergerber B., Hirschel B., Vernazza P., Glass T. R., Jeannin A. etal. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51: 1314-1322.
2. Dia A., Marcellin F., Bonono R. C., Boyer S., Bouhnik A. D., Protopopescu C. etal. Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey). Sex Transm Infect 2010; 86: 148-154.
3. Kalichman S. C., Cherry C., White D., Jones M., Grebler T., Kalichman M. O. etal. Sexual HIV transmission and antiretroviral therapy: a prospective cohort study of behavioral risk factors among men and women living with HIV/AIDS. Ann Behav Med 2011; 42: 111-119.
4. Chaudhry A. A., Botsko M., Weiss L., Egan J. E., Mitty J., Estrada B. etal. Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care. J Acquir Immune Defic Syndr 2011; 56: S14-21.
5. Samet J. H., Pace C. A., Cheng D. M., Coleman S., Bridden C., Pardesi M. etal. Alcohol use and sex risk behaviors among HIV-infected female sex workers (FSWs) and HIV-infected male clients of FSWs in India. AIDS Behav 2010; 14: S74-83.
6. Newville H., Haller D. L. Psychopathology and transmission risk behaviors in patients with HIV/AIDS. AIDS Care 2010; 22: 1259-1268.
7. Arasteh K., Des Jarlais D. C. At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care STDS 2009; 23: 657-661.
8. Theall K. P., Clark R. A., Powell A., Smith H., Kissinger P. Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS Behav 2007; 11: 205-215.
9. Shuper P. A., Neuman M., Kanteres F., Baliunas D., Joharchi N., Rehm J. Causal considerations on alcohol and HIV/AIDS-a systematic review. Alcohol Alcohol 2010; 45: 159-166.
10. Hendershot C. S., Stoner S. A., Pantalone D. W., Simoni J. M. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 2009; 52: 180-202.
11. Boyer S., Clerc I., Bonono C. R., Marcellin F., Bile P. C., Ventelou B. Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: individual and healthcare supply-related factors. Soc Sci Med 2011; 72: 1383-1392.
12. Cook R. L., Sereika S. M., Hunt S. C., Woodward W. C., Erlen J. A., Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med 2001; 16: 83-88.
13. Samet J. H., Horton N. J., Meli S., Freedberg K. A., Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res 2004; 28: 572-577.
14. Samet J. H., Horton N. J., Traphagen E. T., Lyon S. M., Freedberg K. A. Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res 2003; 27: 862-867.
15. Hahn J. A., Samet J. H. Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep 2010; 7: 226-233.
16. Wiley T. E., McCarthy M., Breidi L., McCarthy M., Layden T. J. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28: 805-809.
17. Davis C. G., Thake J., Vilhena N. Social desirability biases in self-reported alcohol consumption and harms. Addict Behav 2010; 35: 302-311.
18. Roux P., Cohen J., Lascoux-Combe C., Sogni P., Winnock M., Salmon-Ceron D. etal. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Drug Alcohol Depend 2011; 116: 228-232.
19. Loko M. A., Salmon D., Carrieri P., Winnock M., Mora M., Merchadou L. etal. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis 2010; 10: 303.
20. Alberti A., Clumeck N., Collins S., Gerlich W., Lundgren J., Palu G. etal. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005; 42: 615-624.
21. Dhumeaux D., Marcellin P., Lerebours E. Treatment of hepatitis C. The 2002 French consensus. Gut 2003; 52: 1784-1787.
22. Galmiche J. P. French consensus conference on hepatitis C: screening and treatment. Gut 1998; 42: 892-898.
23. Anon. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.
24. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293.
25. Bohn M. J., Babor T. F., Kranzler H. R. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol 1995; 56: 423-432.
26. Gache P., Michaud P., Landry U., Accietto C., Arfaoui S., Wenger O. etal. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res 2005; 29: 2001-2007.
27. Heeb J. L., Gmel G. Measuring alcohol consumption: a comparison of graduated frequency, quantity frequency, and weekly recall diary methods in a general population survey. Addict Behav 2005; 30: 403-413.
28. Roux P., Fugon L., Winnock M., Salmon-Ceron D., Lacombe K., Sogni P. etal. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Addiction 2012; 107: 152-159.
29. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 3: 385-491.
30. Fuhrer R., Rouillon F. La version française de l'échelle CES-D. Description and translation of the autoevaluation scale (in French). Psychiatrie et Psychobiologie 1989; 4: 163-166.
31. Fisk J. D., Ritvo P. G., Ross L., Haase D. A., Marrie T. J., Schlech W. F. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18: S79-83.
32. Le Moing V., Chene G., Carrieri M. P., Alioum A., Brun-Vezinet F., Piroth L. etal. Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS 2002; 16: 21-29.
33. Marcellin F., Preau M., Ravaux I., Dellamonica P., Spire B., Carrieri M. P. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials 2007; 8: 320-327.
34. Di Martino V., Rufat P., Boyer N., Renard P., Degos F., Martinot-Peignoux M. etal. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001; 34: 1193-1199.
35. Lewden C., Salmon D., Morlat P., Bevilacqua S., Jougla E., Bonnet F. etal. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34: 121-130.
36. Carrieri M. P., Tamalet C., Vlahov D., Yahi N., Chesney M., Moatti J. P. Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users. Addict Biol 1999; 4: 197-202.
37. Doyle T., Smith C., Vitiello P., Cambiano V., Johnson M., Owen A. etal. Plasma HIV-1 RNA detection below 50 Copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2012; 54: 724-732.
38. Michel L., Carrieri M. P., Fugon L., Roux P., Aubin H. J., Lert F. etal. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention. AIDS Care 2010; 22: 1136-1145.